The earlier the better? Or better late than never? Dose optimization in oncology.
作者信息
Harvey R Donald
机构信息
Departments of Hematology and Medical Oncology and Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, USA.
Winship Cancer Institute of Emory University, Atlanta, GA, USA.
出版信息
J Natl Cancer Inst. 2023 May 8;115(5):485-487. doi: 10.1093/jnci/djad042.
Abstract
摘要
相似文献
1
The earlier the better? Or better late than never? Dose optimization in oncology.越早越好？还是亡羊补牢，为时未晚？肿瘤学中的剂量优化。
J Natl Cancer Inst. 2023 May 8;115(5):485-487. doi: 10.1093/jnci/djad042.
2
Oncology changes and the therapy radiographer.肿瘤学的变化与放射治疗技师
Radiography. 1985 May-Jun;51(597):149-54.
3
Is it the right time for multidisciplinarity in Spanish clinical oncology? I think so.西班牙临床肿瘤学的多学科合作时机是否恰当？我认为是恰当的。
Clin Transl Oncol. 2010 May;12(5):387-8. doi: 10.1007/s12094-010-0522-8.
4
Exploring the Idea of a New Form of External-beam Therapy.探索一种新型外照射疗法的构想。
Radiol Technol. 2017 Jul;88(6):675-678.
5
The Principles and Practice of Re-irradiation in Clinical Oncology: An Overview.《临床肿瘤再放射治疗的原则与实践：概述》。
Clin Oncol (R Coll Radiol). 2018 Feb;30(2):67-72. doi: 10.1016/j.clon.2017.11.014. Epub 2017 Dec 9.
6
The impact on oncology of the interaction of radiation therapy and radiobiology.放射治疗与放射生物学相互作用对肿瘤学的影响。
Clin Transl Oncol. 2006 Feb;8(2):83-93. doi: 10.1007/s12094-006-0163-0.
7
Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology.英国早期乳腺癌的非手术治疗：放疗分割方案。皇家放射科医师学院临床肿瘤学系临床审计小组委员会及临床肿瘤学联合委员会。
Clin Oncol (R Coll Radiol). 1995;7(4):223-6. doi: 10.1016/s0936-6555(05)80604-1.
8
Commentary: lessons in pediatric neuropsycho-oncology: what we've learned since Johnny Gunther.评论：儿科神经肿瘤学的经验教训：自约翰尼·冈瑟以来我们所学到的东西。
J Pediatr Psychol. 2007 Oct;32(9):1038-9. doi: 10.1093/jpepsy/jsm066. Epub 2007 Sep 10.
9
[The US-Japan Seminar 1984. Advances and new technics in radiation oncology research--an overview].[1984年美日研讨会。放射肿瘤学研究的进展与新技术——综述]
Nihon Gan Chiryo Gakkai Shi. 1985 Jul 20;20(6):1123-35.
10
[Therapeutic approach in pediatric oncology].[儿科肿瘤学的治疗方法]
Rev Med Liege. 1996 Apr;51(4):276-9.
引用本文的文献
1
Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology.证据的总体情况：优化肿瘤学中的剂量选择策略
J Clin Oncol. 2025 Jul 24:JCO2500488. doi: 10.1200/JCO-25-00488.
2
Sex differences in the pharmacokinetics of anticancer drugs: a systematic review.抗癌药物药代动力学中的性别差异：一项系统评价。
ESMO Open. 2024 Dec;9(12):104002. doi: 10.1016/j.esmoop.2024.104002. Epub 2024 Dec 10.
本文引用的文献
1
Dose optimization during drug development: whether and when to optimize.药物开发过程中的剂量优化：是否以及何时进行优化。
J Natl Cancer Inst. 2023 May 8;115(5):492-497. doi: 10.1093/jnci/djac232.
2
All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring-Why Take the Slow Lane.所有优化给药途径都通向治疗药物监测——为何要选择慢车道。
JAMA Oncol. 2022 Dec 1;8(12):1733-1735. doi: 10.1001/jamaoncol.2022.4452.
3
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.肿瘤学 I 期临床试验设计与实施：变革之时——MDICT 指南 2022。
Ann Oncol. 2023 Jan;34(1):48-60. doi: 10.1016/j.annonc.2022.09.158. Epub 2022 Sep 29.
4
Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer.肿瘤学家对转移性癌症患者个体化剂量选择的看法。
JCO Oncol Pract. 2022 Nov;18(11):e1807-e1817. doi: 10.1200/OP.22.00427. Epub 2022 Sep 20.
5
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study.基于治疗药物监测的肿瘤口服靶向治疗精准剂量调整：一项前瞻性多中心研究。
Ann Oncol. 2022 Oct;33(10):1071-1082. doi: 10.1016/j.annonc.2022.06.010. Epub 2022 Jun 28.
6
The Drug-Dosing Conundrum in Oncology - When Less Is More.肿瘤学中的给药难题——少即是多。
N Engl J Med. 2021 Oct 14;385(16):1445-1447. doi: 10.1056/NEJMp2109826. Epub 2021 Oct 9.
7
Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities?分子靶向药物的 I 期临床试验：我们是否应该更加关注迟发性毒性？
J Clin Oncol. 2011 May 1;29(13):1728-35. doi: 10.1200/JCO.2010.31.9236. Epub 2011 Mar 28.
Zotero 插件